Solventum Corporation

SOLV Healthcare Medical - Care Facilities NYSE

PDF Back to Search

$85.43

+$0.17 (+0.20%)

Open: $84.72 | High: $85.89 | Low: $84.63 | Prev Close: $85.26

Market Cap: $14.82B

Volume: 894K | Avg: 1.1M

Last updated: December 05, 2025 at 10:06 PM
Investment Rating
A

Buy

Overall Score: 80/100

Rating Breakdown:
DCF Score 5/5
100%
Strong Buy
ROE Score 5/5
100%
Strong Buy
ROA Score 5/5
100%
Strong Buy
D/E Score 1/5
20%
Strong Sell
P/E Score 3/5
60%
Neutral
P/B Score 3/5
60%
Neutral
Add to Watchlist Add to Portfolio
Stock Score Analysis
E

Stock Score: 330

Comprehensive Quality Assessment

Component Breakdown:
Efficiency 0
Financial Health 30
Growth 0
Market Sentiment 0
Risk 0
Lower is better
Valuation 0
Momentum 0
View Full Stock Score Dashboard
Valuation Metrics
Valuation Ratios
P/E Ratio 9.81
P/B Ratio 2.99
P/S Ratio 1.76
EPS $8.71
Beta 0.46
Shares Outstanding 173.44M
Price Range & Moving Averages
52-Week High $88.20
52-Week Low $60.70
SMA 50 $74.54
SMA 200 $73.33
Earnings
Next Earnings November 06, 2025 09:00 PM ET
Financial Ratios
Margins
Gross Margin 54.1%
Operating Margin 26.1%
Net Margin 18.1%
Returns
ROE 41.0%
ROA 10.9%
Liquidity & Leverage
Debt/Equity 1.03
Current Ratio 1.50
Quick Ratio 1.14
Balance Sheet
Total Assets $14.46B
Total Liabilities $11.50B
Total Equity $2.96B
Cash $762.00M
Total Debt $8.01B
Net Debt $7.25B
Income Statement
Revenue $8.25B
Gross Profit $4.59B
Operating Income $1.04B
Net Income $479.00M
EBITDA $1.53B
Revenue/Share $48.20
Cash Flow
Operating CF $1.19B
CapEx $380.00M
Free Cash Flow $805.00M
Book Value/Share $28.61
Tangible Book/Share $-14.33
Equity/Share $28.61
Technical Indicators
RSI (14) 92.76 Overbought
MACD
3.70 Signal: 3.14
Volatility 32.17%
Trading Signal Overbought
Performance & Returns
Total Returns
1 Year +15.48%
Risk-Adjusted Returns
Sharpe Ratio 0.54 Fair
Volatility (Ann.) 34.15% Moderate
vs S&P 500 (SPY)
SOLV (1Y) +15.48%
S&P 500 (1Y) +11.86%
Alpha (Excess Return) +3.61%
Risk-free rate: 4.5% (3-month US Treasury) • Based on 199 trading days
Sector Comparison (Healthcare)
Compared to 59 peers in Healthcare
Metric SOLV Sector Avg Percentile
P/E Ratio 9.81 31.57 10%
P/B Ratio 2.99 -0.61 48%
ROE (%) 41.04% 9.27% 90%
Net Margin (%) 18.14% 9.91% 70%
Stock Score 330 507.0 0%
1Y Return (%) +15.48% +4.23% 75%
Percentile: 0% = worst in sector, 100% = best in sector
Historical Price Analysis (Last 200 Days)
Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
SOLV $85.43 $85.38 $85.17 $82.63 $74.54 $73.33 92.76 3.70 32.17% 929682 Neutral Bullish Stack
Candlestick Patterns

There wasn't any recognizable pattern for the SOLV stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
SOLV These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? Neutral fool.com Read More
SOLV Advisors Asset Management Inc. Lowers Stake in Solventum Corporation $SOLV Neutral defenseworld.net Read More
SOLV Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Neutral seekingalpha.com Read More
SOLV Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Circle Internet, Cloudflare, Danaher, Inspire Medical, Six Flags, Workday and More Neutral 247wallst.com Read More
SOLV Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity Neutral marketbeat.com Read More
Company Information

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

CEO Bryan C. Hanson
Employees 22000
Country US
IPO Date 2024-04-01
Exchange NYSE
Website https://www.solventum.com
Sector Healthcare
Industry Medical - Care Facilities
Similar Stocks (Healthcare - Medical - Care Facilities)
HCA

HCA Healthcare, Inc.

Price: $486.70
Change: -0.20%
Market Cap: $1181B
P/E: 18.83
Score: D (530)
View Details
UHS

Universal Health Services, Inc.

Price: $231.08
Change: +0.21%
Market Cap: $1489B
P/E: 11.00
Score: D (590)
View Details
DVA

DaVita Inc.

Price: $117.39
Change: +0.09%
Market Cap: $8287B
P/E: 12.13
Score: E (500)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.

Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.